OpenLobby.EU
Explore

European Partnership for innovative health

Research and innovation

The proposed Partnership for “Innovative Health”, envisaged under Horizon Europe, aims to provide a collaborative platform for precompetitive R&I where small and big companies can join forces with researchers, patients, healthcare professionals and regulators. This cooperation with partners such as the pharmaceutical, diagnostics, medical devices, imaging, biotech and digital industries shall help accelerating the development and uptake of innovation in the area of public health.

Links

Public consultation

ID: 11906

Lobbying Activity

23 responses

Consultation response

European Federation of Pharmaceutical Industries and Associations, 27 Aug 2019

EFPIA welcomes the roadmap for a “European Partnership for innovative health” under Horizon Europe, and supports and supports Option 2 (Institutional Partnership under TFEU Article 187) as an enabler to address the challenges, and deliver the expected beneficial impact on society, patients,…

Consultation response

MedTech Europe, 26 Aug 2019

The proposal for the European Partnership on Innovative Health recognises the key impact of the European Health industrial sector, including medical technology, as a strong driver for innovation, economic and social impact, growth and jobs. We support the problem definition and the proposal for an…

Consultation response

European Patients' Forum (EPF), 27 Aug 2019

The European Patients’ Forum (EPF) welcomes the European Commission’s roadmap on proposal for a Council Regulation for a European Partnership on Innovative Health under Horizon Europe. EPF fully agrees with the key drivers behind the initiative (outlined in the section “problem the initiative aims…

Consultation response

European Confederation of Independent Trade Unions, 21 Aug 2019

CESI (https://www.cesi.org/), the European Confederation of Independent Trade Union, is an organization which represents the interests of 38 trade unions from 21 European countries, amounting to roughly 5 million public and private sector employees. Most of CESI’s affiliates are working in the…

Consultation response

European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry, 27 Aug 2019

COCIR is glad to provide our feedback to the European Commission’s roadmap towards a Partnership for Innovative Health under Horizon Europe. European Commission has clearly identified the challenges that Europe is facing in the healthcare arena. The future Partnership could be a unique model…

Consultation response

AGE Platform Europe, 8 Aug 2019

In part A "Description of the problem the initiative aims to tackle", it is rightly mentioned that the EU has an ageing population and a rising burden of diseases. Yet we are missing a reference to preventive care. The European partnership on Innovative Health should cover the full spectrum of…

Consultation response

ACT | The App Association, 27 Aug 2019

Please find attached comments of ACT | The App Association's Connected Health Initiative (CHI) on the EC's Roadmap Consultation titled "European Partnership for innovative health (Horizon Europe programme)." We are more than happy to assist in any way we can moving forward as well. ACT | The App…

Consultation response

European Brain Council, 5 Aug 2019

It is our conviction that a robust European Partnership on Innovative Health is a key requisite for accelerating the development of novel treatments, alleviate the burden of a large number of non-communicable diseases, improve patient diagnosis and care as well as improve health outcomes for…

Global Health Advocates demand end to industry research dominance

GLOBAL HEALTH ADVOCATES, 26 Aug 2019

GHA proposes reducing industry presence on the governing board to ensure a stakeholder balance. They advocate for mandatory open access and equitable pricing for products resulting from public funding. The partnership should prioritize neglected diseases based on public health needs rather than commercial profitability.
This would secure greater decision-making power for civil society organizations in health policy.
Major pharmaceutical corporations would lose their current dominant control over strategic research agendas.

Consultation response

European Social Insurance Platform AISBL, 27 Aug 2019

The European Social Insurance Platform (ESIP) generally welcomes the aim of the European Partnerships as described in Article 8 of the draft legislation on Horizon Europe. With view to the previous Innovative Medicines Initiatives, we support the Commission’s intention to continue the work…

Consultation response

European Society for Paediatric Oncology, 27 Aug 2019

SIOP Europe – the European Society for Paediatric Oncology representing paediatric cancer clinicians and academia welcomes Innovative Health as a candidate for a European Partnership in Horizon Europe. We particularly identify with the objective to address high unmet health needs where…

Consultation response

European Federation of Nurses Associations, 20 Aug 2019

It is key for EFN to foster a co-creation environment: innovation in health should empower patients and frontline nurses, moving towards an integrated care system based on proactive/empowered health-aware patient/citizen. We need to ensure that the innovation tools, and the data revolution supports…

Consultation response

European Organisation for Research and Treatment of Cancer, 27 Aug 2019

Several authors have demonstrated that the majority of the new cancer agents do not translate into a clinically meaningful benefit for patients such as survival or quality of life. Nevertheless, the vast majority of these agents do get on the market while limited information is known on such agents…

Consultation response

EuroHealthNet, 27 Aug 2019

EuroHealthNet is a European Partnership that aims to improve health, equity and wellbeing through action on the social determinants of health and health inequalities, disease prevention and health promotion. It is therefore a reference to these aspects of public health that we miss in the…

Consultation response

ReAct - Action on Antibiotic Resistance, 27 Aug 2019

The public interest should be the core of any European partnership. ReAct’s prior experience within previous partnerships funded through IMI2, and in particular DRIVE-AB (1), revealed significant conflicts of interest when there was full participation of drug companies in shaping policy…

Consultation response

University College Dublin – National University of Ireland, Dublin, 27 Aug 2019

University College Dublin (UCD) is Ireland’s largest university and one of Europe’s most research-intensive. UCD is committed to solving global challenges, in particular delivering on the ambitions set out in the United Nations Sustainable Development Goals, in partnership with others. Over the…

Consultation response

European Institute of Womens Health,clg, 27 Aug 2019

The European Institute of Women’s Health (EIWH) welcomes the proposal for a Council Regulation for a European Partnership for Innovative Health under Horizon Europe. The EIWH believes that diverse, interdisciplinary and cross-sectorial partnerships has the potential to contribute to the development…

Consultation response

Vlaamse Instelling voor Technologisch Onderzoek, 27 Aug 2019

VITO supports the European Commission’s proposal for a Council Regulation for a European Partnership on Innovative Health under Horizon Europe. Concerning the policy options VITO considers partnerships beyond the regular Horizon Europe calls to be important. An engaged long-term alignment of…

Consultation response

Biobanking and Biomolecular resources Research Infrastructure-European Research Infrastructure Consortium, 27 Aug 2019

We strongly agree with the Commission’s assessment on the success of the past European Partnership in health. Academia and research-intensive health industries need a vibrant, world-class, inter-connected health and research ecosystem to effectively translate ideas and knowledge into health…

Consultation response

LifeTime Initiative, 27 Aug 2019

LifeTime strongly supports an institutional European Partnership on Innovative Health under Horizon Europe whose overall objective to facilitate technology convergence and understanding of diseases perfectly aligns with the vision of our initiative. LifeTime (https://lifetime-fetflagship.eu/), a…

Consultation response

IrRADIARE, Investigação e Desenvolvimento em Engenharia e Ambiente, Lda, 14 Aug 2019

We firmly believe that a European Partnership on Innovative Health could give a tremendous contribution towards the sustainability of the European Healthcare system. Option 2 seems the only viable pathway to give a considerable push in this direction. There is a huge necessity to bring together…

Consultation response

Institut d'encouragement de la recherche scientifique et de l'innovation de Bruxelles, 26 Aug 2019

This partnership covers very relevant topics in the health sector and we welcome its international scope and its strong incentive for various actors to work with each other. However we would like to point out the importance of securing an access to SMEs active in the health sector in this…

Consultation response

Cáritas Diocesana de Coimbra, 13 Aug 2019

We agree with the assumption that a more structured partnership may provide higher focus and targeted results on the objectives that are prioritized. Therefore, we would consider more adequate to have on of these models: - A co-programmed European Partnership (option 1) is based on drawing up…